{'text': 'Sanofi Pasteur Contributes Generously to United Way of Monroe Campaign', 'publisher': {'href': 'https://www.3blmedia.com', 'title': '3BL Media'}, 'created_at': 'Thu, 17 Dec 2015 08:00:00 GMT', 'description': 'Sanofi Pasteur Contributes Generously to United Way of Monroe Campaign  3BL Media', 'url': 'https://news.google.com/rss/articles/CBMimgFBVV95cUxOOW5sSGVkcHRYbE95VHhBUEdQa09KajdQZmwxVURubE10X1BQN0JxbEh2NWRFNnhnYzVYM2xBeXVSN000TzI5QnZsaU50dUkzRWh4OFNLQzhpMHpGWkhRMDRTX1ZuSkdheDBSamxIYmM0ZHNic1V0cXZIRUVUV284aFQwRXdKREpwcVJyV1hGUFl3MUROaTJNLXV3?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Lilly gets its Lantus copycat Basaglar approved by FDA—but not as a biosimilar', 'publisher': {'href': 'https://www.biopharmadive.com', 'title': 'BioPharma Dive'}, 'created_at': 'Thu, 17 Dec 2015 08:00:00 GMT', 'description': 'Lilly gets its Lantus copycat Basaglar approved by FDA—but not as a biosimilar  BioPharma Dive', 'url': 'https://news.google.com/rss/articles/CBMiuAFBVV95cUxPRVRpRmFscXJZd0VUU3lXM2xDVWc4aVZCVzhJb3ZjMUhJQVZLRXlpY3FNYzVVak9NM0Nvd2VicFVpM1VBdk1NTjlib0JNelM4RTB2Y1ZtVDJiTzNaTUttTG1GY3pqUThRaXMyMDc1RHZSenBsbEVCVzc4empFc1k2X2xCQUd5NTA1S3RwWWtWNXlJWWtHdjExTGxWZWI5aHFpMVhleHdDZ1NPYy1GcG1PNmh4QW5QZHpG?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Lantus competitor Basaglar wins FDA approval', 'publisher': {'href': 'https://www.mdedge.com', 'title': 'MDedge'}, 'created_at': 'Thu, 17 Dec 2015 08:00:00 GMT', 'description': 'Lantus competitor Basaglar wins FDA approval  MDedge', 'url': 'https://news.google.com/rss/articles/CBMiqAFBVV95cUxPUV9oaXlianUyRVI5N3RrWnk1WVQxZ2dvNS02RkktRFl4WlJaT2Q3VDg3SGRkWUtOY05kaGJOMXVaaE1XRTg3QnFDVXozZE5UVzhEMktfU1RabXZBdFhMZUdiUENzMVNZVlM0cVFfT0V0TXZHalBSSTZKMktpTk5oUFBVSnpGZkRoMFBvWFpGQVFQd1JnaEoyTE5zSlB2bjVBemZWM0pyeTE?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Yet another reason Martin Shkreli was under federal scrutiny this week', 'publisher': {'href': 'https://www.washingtonpost.com', 'title': 'The Washington Post'}, 'created_at': 'Thu, 17 Dec 2015 08:00:00 GMT', 'description': 'Yet another reason Martin Shkreli was under federal scrutiny this week  The Washington Post', 'url': 'https://news.google.com/rss/articles/CBMiygFBVV95cUxQcUNPSWxFbzVvaWFKZDRxZUxSdDM5elY3eWxGOE5EMVR1dDdDOXRsYmh5T01aQUJraklESFp4Q2VZYm9DcFo2U01ZSTZ4d3YxbGc4U2s4VDFBSU02OTF0MHBHYzQ4RmNlVkF6YU5KWlIzUnZFaFJvNldXZkJmaElxeGtNTzNpZlExaV9sR0tpMVdMcjNZZENGQlpZRm9IV1lQbmxMTGl5a1AyR0E2aV9sb0FFRVh4S09xenhoaWJsMzk3QmFjZ0JBX0dn?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Lilly Discontinues Development of Liver-Selective Basal Insulin Peglispro', 'publisher': {'href': 'https://diatribe.org', 'title': 'diaTribe Foundation'}, 'created_at': 'Fri, 18 Dec 2015 08:00:00 GMT', 'description': 'Lilly Discontinues Development of Liver-Selective Basal Insulin Peglispro  diaTribe Foundation', 'url': 'https://news.google.com/rss/articles/CBMisgFBVV95cUxNZ2xMMjdmVEZMeUZkNTdrMDFZNUdYWUJrcDJ6RFJjUUhRYWRtTUp6QWNBVG9ndDN3YXpSYVBENmh0UHIyZnZGaHd1Ujk0UDNGa1N2U2lxVnRYV3BXdkpMQ2E1Qy1ib09TajBXOWNsaFpCSlR2OHdXM3JjNjR6Ujk5S3NEWTVEbGtSQzYydWwxRTFEY0F3b2RxYlhzMlpKaU0teERKcjY4V0MyU2FTb2pWNVhn?oc=5&hl=en-US&gl=US&ceid=US:en'}
